CAPITOL COUNSEL LLC

Lobbying for BOEHRINGER INGELHEIM ANIMAL HEALTH US · Animal health.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Georgia · Senate · $50,000.00 income · posted Apr 16, 2026

Lobbying activity 2

Animals

Issues regarding FDA animal drug approval process.

Medical/Disease Research/Clinical Labs

Issues regarding FDA animal drug approval process.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.